Video: Dr. Syed Haider: Healing Vax Injuries and Long COVID

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on InstagramTwitter and Facebook. Feel free to repost and share widely Global Research articles.

***

As the numbers of vaccine injured and long covid sufferers rise after taking injections of pharmaceutical products that long ago met the FDA’s death and injury threshold for declaring a drug too dangerous for public consumption, all too few physicians are effectively addressing their devastating health issues. Dr. Syed Haider, who treats these patients, explains what he’s used that works, which in some cases includes Ivermectin, that has shown to be very effective.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.

This article was originally published on The Whistleblower Newsroom.

Featured image is a screenshot from the video


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]